Discontinuation report TEVA-NORFLOXACIN

Last updated on 2018-10-19 History
Report ID 65013
Drug Identification Number 02237682
Brand name TEVA-NORFLOXACIN
Common or Proper name NORFLOXACIN
Company Name TEVA CANADA LIMITED
Market Status CANCELLED POST MARKET
Active Ingredient(s) NORFLOXACIN
Strength(s) 400MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code J01MA
ATC description QUINOLONE ANTIBACTERIALS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2018-08-31
Remaining supply date 2017-01-01
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2018-10-19 French Compare
v1 2018-10-19 English Compare

Showing 1 to 2 of 2